Core Insights - The 2025 CDCE International Data Center Exhibition will take place in Shanghai from November 18 to 20, 2025, where the company Feiwo Tai will showcase its innovative liquid cooling server protection solutions [1] - The company emphasizes that liquid cooling technology is becoming the primary choice for heat dissipation in the computing service sector due to increasing computing density [1] - Feiwo Tai's solutions address significant challenges such as coolant penetration and chemical corrosion, which traditional protection methods struggle to manage effectively [1] Company Innovations - Feiwo Tai's liquid cooling server solutions have achieved breakthroughs in protecting core electronic components from coolant penetration, high humidity condensation, and chemical corrosion, significantly enhancing device lifespan [1] - The ultra-thin film layer used in the solutions does not compromise heat dissipation performance and is suitable for complex structures like motherboards, chips, and connectors [1] - The materials used are environmentally friendly and have stable processes, enabling mass production of liquid cooling server motherboards for leading clients [1] Market Positioning - Feiwo Tai's nano-coating technology has been widely applied in consumer electronics and automotive electronics, with a notable award for its automotive electronic oil pump protection solution [2] - The company's recent technological iteration for computing servers marks its entry into the trillion-dollar data center market [2] - The company also showcased phase change material (PCM) nano-protection technology, which prevents leakage-related short circuit risks while maintaining heat dissipation performance [2] Environmental Impact - Under the "dual carbon" strategy, the global consensus is shifting towards green transformation in data centers, and Feiwo Tai's technology helps reduce server failure rates and extend equipment lifespan, indirectly lowering electronic waste generation [2] - The company's environmentally friendly material system has received international certifications such as RoHS and REACH, assisting downstream supply chains in meeting ESG standards [2]

Core Insights - FavoTech (688371) has signed a strategic cooperation agreement with Wuxi Langyi New Materials Co., Ltd. to jointly launch the FavoMedNano fluorine-free nano-coating solution, designed for efficient liquid barrier and bacterial protection in the medical and sports fabric sectors [1][2] Company Overview - Langyi New Materials specializes in producing base fabrics and protective products for the medical and sports industries, with a fully automated production system from cotton to finished products, serving leading companies domestically and internationally [1] - FavoTech is a leader in the nano-protection field, with core technologies applied across various sectors including consumer electronics, automotive electronics, and industrial control, successfully utilized in products from top enterprises [1] Product Features - The FavoMedNano solution creates a transparent film layer on fabric surfaces, with a thickness measured in nanometers, allowing water droplets, blood, or sweat to slide off quickly without adhering [1] - The solution forms an invisible barrier on products like band-aids, maintaining a rolling angle stability between 14-16° and a water contact angle of up to 130°, effectively blocking bacteria from entering wounds while ensuring breathability and comfort [2] - The film layer is made from halogen-free and fluorine-free eco-friendly materials, certified for environmental and biocompatibility standards, balancing high protection with safety [2] Market Potential - Market research predicts that the global medical protective textile market will exceed $40 billion by 2027, while the functional sports fabric sector is expected to grow at a compound annual growth rate of 12% [2] - The collaboration aims to combine the technological and industrial strengths of both companies to provide more environmentally friendly, advanced, and superior solutions for functional textiles in the medical and sports industries [2] Strategic Vision - FavoTech's chairman emphasized the company's commitment to redefining product boundaries through nano-technology across various sectors, including medical and sports fields, and aims to enhance the "technology + scenario" dual-driven strategy for broader applications [2]

证券代码：688371 证券简称：菲沃泰 公告编号：2025-048 江苏菲沃泰纳米科技股份有限公司 股东询价转让定价情况提示性公告 股东 Favored Tech Corporation Limited（以下简称"出让方"）保证向江苏菲 沃泰纳米科技股份有限公司（以下简称"菲沃泰"或"公司"）提供的信息内容 不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确性和完整 性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 根据 2025 年 11 月 7 日询价申购情况，初步确定的本次询价转让价格为 18.55 元/股。 一、本次询价转让初步定价 （一）经向机构投资者询价后，初步确定的转让价格为 18.55 元/股。 （二）经出让方与组织券商协商，一致决定启动追加认购程序，追加认购截 止时间不晚于 2025 年 11 月 20 日。 董事会 2025 年 11 月 8 日 二、风险提示 （一）本次询价转让受让方尚存在拟转让股份被司法冻结、扣划等风险。询 价转让的最终结果以中国证券登记结算有限责任公司上海分公司最终办理结果 为准。 （二）本次询价转 ...

Core Points - The company Fivotech (688371.SH) announced a preliminary inquiry transfer price of 18.55 yuan per share based on the inquiry subscription situation as of November 7, 2025 [1] - The seller and the organizing securities firm have agreed to initiate an additional subscription process, with the deadline for additional subscriptions no later than November 20, 2025 [1] - This inquiry transfer does not involve a change in the company's control and will not affect the company's governance structure or ongoing operations [1]

Core Viewpoint - Fivotech (688371.SH) has disclosed the pricing situation for the transfer of shares, with a preliminary transfer price set at 18.55 yuan per share after inquiries with institutional investors [1] Group 1 - The transfer price of 18.55 yuan per share was determined following consultations with institutional investors [1] - The selling party and the organizing brokerage have agreed to initiate an additional subscription process [1] - The deadline for the additional subscription is set no later than November 20, 2025 [1]

Core Viewpoint - The company Fivotech (688371.SH) has disclosed the pricing situation for the transfer of shares based on inquiries from institutional investors, with a preliminary transfer price set at 18.55 yuan per share [1] Group 1 - The transfer price of 18.55 yuan per share was determined after consultations with institutional investors [1] - The selling party and the organizing brokerage have agreed to initiate an additional subscription process [1] - The deadline for the additional subscription is set no later than November 20, 2025 [1]

Core Viewpoint - Favored Tech Corporation Limited plans to transfer 10,064,170 shares of Favored Tech (688371.SH), representing 3.00% of the total share capital, due to its own funding needs. The transfer will not occur through centralized bidding or block trading, and it will not lead to a change in control of the company [1][2]. Group 1: Share Transfer Details - The transferring party, Favored Tech Corporation Limited, currently holds 208,533,334 shares, accounting for 62.16% of the total share capital [1]. - The transfer does not involve a change in control, as the transferring party is the controlling shareholder and actual controller of Favored Tech [2]. Group 2: Financial Performance - Favored Tech was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on August 2, 2022, with an initial public offering (IPO) of 83,868,089 shares at a price of 18.54 yuan per share, raising a total of approximately 155.49 million yuan [2][3]. - The company has experienced continuous losses since its listing, with a net profit attributable to shareholders of -10.67 million yuan in Q1 2023, -10.78 million yuan in Q2 2023, -11.98 million yuan in Q3 2023, and an expected loss of -8.12 million yuan in Q4 2023 [4][5]. - For the entire year of 2023, the company reported a total revenue of 30.89 million yuan, a year-on-year decrease of 21.91%, and a net profit attributable to shareholders of -41.55 million yuan, compared to a profit of 33.33 million yuan in the previous year [5][6].

Group 1 - The core point of the article is that Favored Tech Corporation Limited plans to transfer a total of 10.0642 million shares of Favored Tech (688371.SH), which represents 3.00% of the company's total share capital [1]

股东 Favored Tech Corporation Limited（以下简称"出让方"）保证向江苏菲沃 泰纳米科技股份有限公司（以下简称"菲沃泰"或"公司"）提供的信息内容不存在 任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确性和完整性依法 承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 拟参与菲沃泰首发前股东询价转让（以下简称"本次询价转让"）的股东为 Favored Tech Corporation Limited（中文名称：菲沃泰有限公司）； 出让方拟转让股份的总数为 10,064,170 股，占菲沃泰总股本的比例为 3.00%； 本次询价转让不通过集中竞价交易或大宗交易方式进行，不属于通过二级 市场减持。受让方通过询价转让受让的股份，在受让后 6 个月内不得转让； 本次询价转让的受让方为具备相应定价能力和风险承受能力的机构投资 者。 一、拟参与转让的股东情况 （一）出让方的名称、持股数量、持股比例 证券代码：688371 证券简称：菲沃泰 公告编号：2025-047 江苏菲沃泰纳米科技股份有限公司 股东询价转让计划书 出让方委托中信证券 ...

广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座 1 中信证券股份有限公司 关于江苏菲沃泰纳米科技股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 中信证券股份有限公司（以下简称"中信证券"）受江苏菲沃泰纳米科技股 份有限公司（以下简称"菲沃泰"）股东菲沃泰有限公司（以下简称"出让方"） 委托，组织实施本次菲沃泰首发前股东向特定机构投资者询价转让（以下简称"本 次询价转让"）。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法（试行）》《上海证券交易所科创板股票上市规则（2025 年 4 月修订）》《上海证券交易所科创板上市公司自律监管指引第 4 号——询价 转让和配售（2025 年 3 月修订）》（以下简称"《询价转让和配售指引》"）等 相关规定，中信证券对参与本次询价转让股东的相关资格进行核查，并出具本核 查意见。 一、本次询价转让的委托 中信证券收到出让方关于本次询价转让的委托，委托中信证券组织实施本次 询价转让。 二、关于参与本次询价转让股东相关资格的核查情况 （一）核查过程 根据相关法规要求，中信证券对出让方的相关资格进行了核查。 ...